NCT06913374View on ClinicalTrials.gov

The Study of Different Cycles of High-dose Dexamethasone in the Treatment of ITP

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

May 30, 2026

Study Completion Date

May 30, 2027

Conditions
Thrombocytopenia
Interventions
DRUG

Dexamethasone

given orally at 40 mg per day for two cycles (days1-4, and days 11-14).

DRUG

Dexamethasone

given orally at 40 mg per day for three cycles (days1-4, days 11-14, and days 21-24).

Trial Locations (1)

273300

Qilu hospital of Shandong university, Jinan

All Listed Sponsors
lead

Shandong University

OTHER

NCT06913374 - The Study of Different Cycles of High-dose Dexamethasone in the Treatment of ITP | Biotech Hunter | Biotech Hunter